Patent · US Active

Compositions

US8841264B2 · kind B2 · utility

21Cited by
12References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 12, 2007
Grant dateSep 23, 2014
Priority date
Expiry dateAug 14, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compositions containing a combination of hydroxytyrosol and resveratrol or liqustilide or (−)-epigallocatechin gallate or honokiol or genistein or Magnolia bark extract or a combination of oleuropein and resveratrol or ligustilide are used to treat inflammatory disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.